Crewe Advisors LLC Myriad Genetics Inc Call Options Transaction History
Crewe Advisors LLC
- $856 Million
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MYGN
# of Institutions
195Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$386 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$261 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$209 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$198 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$140 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.09B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...